Interestingly, GA significantly modulates expression levels of SUMO1, Ubc9, and SENP1 in E. granulosus infection-driven hepatic fibrosis models, further indicating the SUMOylation pathway as a key hub of the anti-fibrotic effect of GA. Here, UBE2I is linked to Hepatic fibrosis.